On April 17, 2026, Dare Bioscience, Inc. completed an offering of 20,000 Investor Units for $100,000, with each unit consisting of one share of Series A Preferred Stock and two warrants for common stock. This was part of a larger plan to issue up to 4,854,000 units as filed with the SEC, enabling potential growth and investment opportunities.